Researchers at the Universitat Politècnica de València and the Universitat de Girona have developed a new method for continuous glucose monitoring in patients with type 1 diabetes. It is based on a new calibration algorithm ...
May 8, 2013
0
0
The fixed combination of the drugs saxagliptin and metformin (Komboglyze) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the "Act ...
Apr 29, 2013
0
0
A new scoring system takes a holistic view of the effect of obesity treatment in patients.
Apr 23, 2013
0
0
Between 600,000 and 800,000 Austrians have diabetes mellitus. This "sugar disease", as it is known, can itself already be treated very effectively. The later consequences of diabetes, however, which mostly affect the blood ...
Nov 14, 2012
0
0
Patients with Type 2 Diabetes may face an increased risk for Barrett's Esophagus (BE), regardless of other risk factors including smoking, alcohol consumption, obesity and gastroesophageal reflux disease (GERD), according ...
Oct 22, 2012
0
0
One of life's certainties is that everyone ages. However, it's also certain that not everyone ages at the same rate. According to recent research being presented this week, the cardiovascular system of people with type 2 ...
Oct 11, 2012
0
0
Obstructive sleep apnea (OSA) is independently associated with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM), according to a new study from researchers in the UK. The severity of DPN ...
Jun 15, 2012
3
1
Research led by the University of Leicester concludes that people newly diagnosed with Type 2 diabetes need ongoing advice from GPs sustained over a number of years rather than a one-off session when they are first diagnosed.
Jun 13, 2012
0
0
Among African Americans with type 1 diabetes mellitus, narrower central retinal arteriolar equivalent (average diameter of the small arteries in the retina) is associated with an increased risk of six-year incidence of any ...
May 14, 2012
0
0
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
Feb 29, 2012
0
0
